Samsung Biologics unveils $897 mln manufacturing deals for Pfizer
South Korea's Samsung Biologics (207940.KS) announced on Tuesday two deals with Pfizer (PFE.N) worth a combined $897 million to manufacture products for the U.S. pharmaceutical giant.The latest deals will see the biotech division of the Samsung Group prod
South Korea's Samsung Biologics (207940.KS) announced on Tuesday two deals with Pfizer (PFE.N) worth a combined $897 More... https://www.emirates247.com/business/corporate/samsung-biologics-unveils-897-mln-manufacturing-deals-for-pfizer-2023-07-05-1.713852
Emirates for everyone

What's your reaction?


You may also like

Comments

https://www.iheartemirates.com/assets/images/user-avatar-s.jpg

0 comment

Write the first comment for this!

Facebook Conversations